BriaCell Therapeutics (BCTXW) Competitors

$0.21

+0.02 (+10.53%)

(As of 07/26/2024 ET)

Stock Analysis Chart Competitors Financials Headlines Ownership SEC Filings Short Interest Trends

BCTXW vs. ATNFW, SXTPW, DRTSW, APLMW, BCDAW, CDIOW, CTCXW, SAVAW, CELUW, and CEROW

Should you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioCardia (BCDAW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

BriaCell Therapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and BriaCell Therapeutics (NASDAQ:BCTXW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations.

: In the previous week, BriaCell Therapeutics had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for BriaCell Therapeutics and 1 mentions for 180 Life Sciences. BriaCell Therapeutics' average media sentiment score of 1.89 beat 180 Life Sciences' score of 0.65 indicating that 180 Life Sciences is being referred to more favorably in the media.
Company Overall Sentiment
180 Life Sciences Very Positive
BriaCell Therapeutics Positive
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
BriaCell Therapeutics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
BriaCell Therapeutics N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
BriaCell Therapeutics N/A N/A N/A N/A N/A
: 180 Life Sciences and BriaCell Therapeutics both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
180 Life Sciences N/A N/A
BriaCell Therapeutics N/A N/A

Company	Overall Sentiment
180 Life Sciences	Very Positive
BriaCell Therapeutics	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
BriaCell Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
BriaCell Therapeutics	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
BriaCell Therapeutics	N/A	N/A	N/A	N/A	N/A

Company	Underperform	Outperform
180 Life Sciences	N/A	N/A
BriaCell Therapeutics	N/A	N/A

Summary

180 Life Sciences and BriaCell Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.

Ad The Oxford Club

Man Who Called Nvidia at $1.10 Says Buy This Now...

In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.

Watch Alex's "Next Magnificent Seven" presentation now.

Get BriaCell Therapeutics News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BCTXW vs. The Competition

Export to Excel

Metric	BriaCell Therapeutics	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$148.81M	$5.31B	$8.19B
Dividend Yield	N/A	3.49%	2.72%	3.96%
P/E Ratio	N/A	91.50	152.08	18.37
Price / Sales	N/A	17,674.37	2,071.74	88.82
Price / Cash	N/A	12.04	35.89	34.13
Price / Book	N/A	6.65	4.95	4.51
Net Income	N/A	-$19.78M	$112.29M	$216.36M
7 Day Performance	24.50%	1.01%	2.73%	1.82%
1 Month Performance	-20.79%	6.12%	6.97%	7.09%
1 Year Performance	-90.79%	12.18%	11.22%	4.88%

BriaCell Therapeutics Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 +12.6%	N/A	+7.5%	$0.00	N/A	4	Positive News Gap Down
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars 0.00 / 5 stars	$0.07 -12.4%	N/A	-85.1%	$0.00	$352,864.00	2	Gap Down
DRTSW Alpha Tau Medical	0 of 5 stars 0.00 / 5 stars	$0.25 +13.0%	N/A	-44.5%	$0.00	N/A	121	Positive News Gap Up
APLMW Apollomics	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-80.0%	$0.00	N/A	59	Gap Down
BCDAW BioCardia	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-98.4%	$0.00	$468,000.00	16	Positive News Gap Up
CDIOW Cardio Diagnostics	0 of 5 stars 0.00 / 5 stars	$0.04 -19.2%	N/A	N/A	$0.00	$32,993.00	7	Gap Down
CTCXW Carmell	0 of 5 stars 0.00 / 5 stars	$0.09 +5.9%	N/A	N/A	$0.00	$3.73M	9	Gap Down
SAVAW Cassava Sciences	0 of 5 stars 0.00 / 5 stars	$0.03 flat	N/A	N/A	$0.00	N/A	30	Gap Up
CELUW Celularity	0 of 5 stars 0.00 / 5 stars	$0.02 flat	N/A	-70.7%	$0.00	$14.79M	225	Short Interest ↑
CEROW CERo Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.02 flat	N/A	N/A	$0.00	N/A	8	Gap Up